1 Covid-19 Rapid Antigen Market Overview
    1.1 Product Overview and Scope of Covid-19 Rapid Antigen
    1.2 Covid-19 Rapid Antigen Segment by Sample Type
        1.2.1 Global Covid-19 Rapid Antigen Sales Growth Rate Comparison by Sample Type (2022-2028)
        1.2.2 Nasal Swab
        1.2.3 Oral Fluid/Saliva
    1.3 Covid-19 Rapid Antigen Segment by Application
        1.3.1 Global Covid-19 Rapid Antigen Sales Comparison by Application: (2022-2028)
        1.3.2 Hospitals
        1.3.3 Scientific Research
    1.4 Global Covid-19 Rapid Antigen Market Size Estimates and Forecasts
        1.4.1 Global Covid-19 Rapid Antigen Revenue 2017-2028
        1.4.2 Global Covid-19 Rapid Antigen Sales 2017-2028
        1.4.3 Covid-19 Rapid Antigen Market Size by Region: 2017 Versus 2021 Versus 2028
2 Covid-19 Rapid Antigen Market Competition by Manufacturers
    2.1 Global Covid-19 Rapid Antigen Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Covid-19 Rapid Antigen Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Covid-19 Rapid Antigen Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Covid-19 Rapid Antigen Manufacturing Sites, Area Served, Product Type
    2.5 Covid-19 Rapid Antigen Market Competitive Situation and Trends
        2.5.1 Covid-19 Rapid Antigen Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Covid-19 Rapid Antigen Players Market Share by Revenue
        2.5.3 Global Covid-19 Rapid Antigen Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Covid-19 Rapid Antigen Retrospective Market Scenario by Region
    3.1 Global Covid-19 Rapid Antigen Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Covid-19 Rapid Antigen Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Covid-19 Rapid Antigen Market Facts & Figures by Country
        3.3.1 North America Covid-19 Rapid Antigen Sales by Country
        3.3.2 North America Covid-19 Rapid Antigen Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Covid-19 Rapid Antigen Market Facts & Figures by Country
        3.4.1 Europe Covid-19 Rapid Antigen Sales by Country
        3.4.2 Europe Covid-19 Rapid Antigen Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Covid-19 Rapid Antigen Market Facts & Figures by Region
        3.5.1 Asia Pacific Covid-19 Rapid Antigen Sales by Region
        3.5.2 Asia Pacific Covid-19 Rapid Antigen Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Covid-19 Rapid Antigen Market Facts & Figures by Country
        3.6.1 Latin America Covid-19 Rapid Antigen Sales by Country
        3.6.2 Latin America Covid-19 Rapid Antigen Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Covid-19 Rapid Antigen Market Facts & Figures by Country
        3.7.1 Middle East and Africa Covid-19 Rapid Antigen Sales by Country
        3.7.2 Middle East and Africa Covid-19 Rapid Antigen Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Covid-19 Rapid Antigen Historic Market Analysis by Sample Type
    4.1 Global Covid-19 Rapid Antigen Sales Market Share by Sample Type (2017-2022)
    4.2 Global Covid-19 Rapid Antigen Revenue Market Share by Sample Type (2017-2022)
    4.3 Global Covid-19 Rapid Antigen Price by Sample Type (2017-2022)
5 Global Covid-19 Rapid Antigen Historic Market Analysis by Application
    5.1 Global Covid-19 Rapid Antigen Sales Market Share by Application (2017-2022)
    5.2 Global Covid-19 Rapid Antigen Revenue Market Share by Application (2017-2022)
    5.3 Global Covid-19 Rapid Antigen Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Abbott
        6.1.1 Abbott Corporation Information
        6.1.2 Abbott Description and Business Overview
        6.1.3 Abbott Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Abbott Covid-19 Rapid Antigen Product Portfolio
        6.1.5 Abbott Recent Developments/Updates
    6.2 Access Bio
        6.2.1 Access Bio Corporation Information
        6.2.2 Access Bio Description and Business Overview
        6.2.3 Access Bio Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Access Bio Covid-19 Rapid Antigen Product Portfolio
        6.2.5 Access Bio Recent Developments/Updates
    6.3 BD
        6.3.1 BD Corporation Information
        6.3.2 BD Description and Business Overview
        6.3.3 BD Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 BD Covid-19 Rapid Antigen Product Portfolio
        6.3.5 BD Recent Developments/Updates
    6.4 Quidel
        6.4.1 Quidel Corporation Information
        6.4.2 Quidel Description and Business Overview
        6.4.3 Quidel Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Quidel Covid-19 Rapid Antigen Product Portfolio
        6.4.5 Quidel Recent Developments/Updates
    6.5 Fujirebio
        6.5.1 Fujirebio Corporation Information
        6.5.2 Fujirebio Description and Business Overview
        6.5.3 Fujirebio Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Fujirebio Covid-19 Rapid Antigen Product Portfolio
        6.5.5 Fujirebio Recent Developments/Updates
    6.6 Ellume
        6.6.1 Ellume Corporation Information
        6.6.2 Ellume Description and Business Overview
        6.6.3 Ellume Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Ellume Covid-19 Rapid Antigen Product Portfolio
        6.6.5 Ellume Recent Developments/Updates
    6.7 OraSure Technologies
        6.6.1 OraSure Technologies Corporation Information
        6.6.2 OraSure Technologies Description and Business Overview
        6.6.3 OraSure Technologies Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 OraSure Technologies Covid-19 Rapid Antigen Product Portfolio
        6.7.5 OraSure Technologies Recent Developments/Updates
    6.8 Clip Health
        6.8.1 Clip Health Corporation Information
        6.8.2 Clip Health Description and Business Overview
        6.8.3 Clip Health Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Clip Health Covid-19 Rapid Antigen Product Portfolio
        6.8.5 Clip Health Recent Developments/Updates
    6.9 Celltrion Healthcare
        6.9.1 Celltrion Healthcare Corporation Information
        6.9.2 Celltrion Healthcare Description and Business Overview
        6.9.3 Celltrion Healthcare Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Celltrion Healthcare Covid-19 Rapid Antigen Product Portfolio
        6.9.5 Celltrion Healthcare Recent Developments/Updates
    6.10 Salofa Oy
        6.10.1 Salofa Oy Corporation Information
        6.10.2 Salofa Oy Description and Business Overview
        6.10.3 Salofa Oy Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Salofa Oy Covid-19 Rapid Antigen Product Portfolio
        6.10.5 Salofa Oy Recent Developments/Updates
    6.11 iHealth Labs
        6.11.1 iHealth Labs Corporation Information
        6.11.2 iHealth Labs Covid-19 Rapid Antigen Description and Business Overview
        6.11.3 iHealth Labs Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 iHealth Labs Covid-19 Rapid Antigen Product Portfolio
        6.11.5 iHealth Labs Recent Developments/Updates
    6.12 Novegent
        6.12.1 Novegent Corporation Information
        6.12.2 Novegent Covid-19 Rapid Antigen Description and Business Overview
        6.12.3 Novegent Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Novegent Covid-19 Rapid Antigen Product Portfolio
        6.12.5 Novegent Recent Developments/Updates
    6.13 Hangzhou Alltest Biotech
        6.13.1 Hangzhou Alltest Biotech Corporation Information
        6.13.2 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Description and Business Overview
        6.13.3 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Portfolio
        6.13.5 Hangzhou Alltest Biotech Recent Developments/Updates
    6.14 Guangzhou Decheng Biotechnology
        6.14.1 Guangzhou Decheng Biotechnology Corporation Information
        6.14.2 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Description and Business Overview
        6.14.3 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Portfolio
        6.14.5 Guangzhou Decheng Biotechnology Recent Developments/Updates
    6.15 SD Biosensor
        6.15.1 SD Biosensor Corporation Information
        6.15.2 SD Biosensor Covid-19 Rapid Antigen Description and Business Overview
        6.15.3 SD Biosensor Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 SD Biosensor Covid-19 Rapid Antigen Product Portfolio
        6.15.5 SD Biosensor Recent Developments/Updates
    6.16 MP Biomedical
        6.16.1 MP Biomedical Corporation Information
        6.16.2 MP Biomedical Covid-19 Rapid Antigen Description and Business Overview
        6.16.3 MP Biomedical Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 MP Biomedical Covid-19 Rapid Antigen Product Portfolio
        6.16.5 MP Biomedical Recent Developments/Updates
    6.17 Jiangsu Well Biotech
        6.17.1 Jiangsu Well Biotech Corporation Information
        6.17.2 Jiangsu Well Biotech Covid-19 Rapid Antigen Description and Business Overview
        6.17.3 Jiangsu Well Biotech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 Jiangsu Well Biotech Covid-19 Rapid Antigen Product Portfolio
        6.17.5 Jiangsu Well Biotech Recent Developments/Updates
    6.18 CTK Biotech
        6.18.1 CTK Biotech Corporation Information
        6.18.2 CTK Biotech Covid-19 Rapid Antigen Description and Business Overview
        6.18.3 CTK Biotech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.18.4 CTK Biotech Covid-19 Rapid Antigen Product Portfolio
        6.18.5 CTK Biotech Recent Developments/Updates
    6.19 Hangzhou Laihe Biotech
        6.19.1 Hangzhou Laihe Biotech Corporation Information
        6.19.2 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Description and Business Overview
        6.19.3 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.19.4 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Portfolio
        6.19.5 Hangzhou Laihe Biotech Recent Developments/Updates
    6.20 Innovation Scientific
        6.20.1 Innovation Scientific Corporation Information
        6.20.2 Innovation Scientific Covid-19 Rapid Antigen Description and Business Overview
        6.20.3 Innovation Scientific Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.20.4 Innovation Scientific Covid-19 Rapid Antigen Product Portfolio
        6.20.5 Innovation Scientific Recent Developments/Updates
    6.21 Biohit Healthcare
        6.21.1 Biohit Healthcare Corporation Information
        6.21.2 Biohit Healthcare Covid-19 Rapid Antigen Description and Business Overview
        6.21.3 Biohit Healthcare Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.21.4 Biohit Healthcare Covid-19 Rapid Antigen Product Portfolio
        6.21.5 Biohit Healthcare Recent Developments/Updates
    6.22 ACON Biotech
        6.22.1 ACON Biotech Corporation Information
        6.22.2 ACON Biotech Covid-19 Rapid Antigen Description and Business Overview
        6.22.3 ACON Biotech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.22.4 ACON Biotech Covid-19 Rapid Antigen Product Portfolio
        6.22.5 ACON Biotech Recent Developments/Updates
    6.23 Assure Tech
        6.23.1 Assure Tech Corporation Information
        6.23.2 Assure Tech Covid-19 Rapid Antigen Description and Business Overview
        6.23.3 Assure Tech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.23.4 Assure Tech Covid-19 Rapid Antigen Product Portfolio
        6.23.5 Assure Tech Recent Developments/Updates
    6.24 Hangzhou Clongene Biotech
        6.24.1 Hangzhou Clongene Biotech Corporation Information
        6.24.2 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Description and Business Overview
        6.24.3 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.24.4 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Portfolio
        6.24.5 Hangzhou Clongene Biotech Recent Developments/Updates
    6.25 Hangzhou Testsea Biotechnology
        6.25.1 Hangzhou Testsea Biotechnology Corporation Information
        6.25.2 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Description and Business Overview
        6.25.3 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Sales, Revenue and Gross Margin (2017-2022)
        6.25.4 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Portfolio
        6.25.5 Hangzhou Testsea Biotechnology Recent Developments/Updates
7 Covid-19 Rapid Antigen Manufacturing Cost Analysis
    7.1 Covid-19 Rapid Antigen Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Covid-19 Rapid Antigen
    7.4 Covid-19 Rapid Antigen Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Covid-19 Rapid Antigen Distributors List
    8.3 Covid-19 Rapid Antigen Customers
9 Covid-19 Rapid Antigen Market Dynamics
    9.1 Covid-19 Rapid Antigen Industry Trends
    9.2 Covid-19 Rapid Antigen Market Drivers
    9.3 Covid-19 Rapid Antigen Market Challenges
    9.4 Covid-19 Rapid Antigen Market Restraints
10 Global Market Forecast
    10.1 Covid-19 Rapid Antigen Market Estimates and Projections by Sample Type
        10.1.1 Global Forecasted Sales of Covid-19 Rapid Antigen by Sample Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Covid-19 Rapid Antigen by Sample Type (2023-2028)
    10.2 Covid-19 Rapid Antigen Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Covid-19 Rapid Antigen by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Covid-19 Rapid Antigen by Application (2023-2028)
    10.3 Covid-19 Rapid Antigen Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Covid-19 Rapid Antigen by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Covid-19 Rapid Antigen by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Covid-19 Rapid Antigen Sales Growth Rate Comparison by Sample Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Covid-19 Rapid Antigen Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Covid-19 Rapid Antigen Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Covid-19 Rapid Antigen Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Covid-19 Rapid Antigen Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Covid-19 Rapid Antigen Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Covid-19 Rapid Antigen Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Covid-19 Rapid Antigen Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Covid-19 Rapid Antigen Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Covid-19 Rapid Antigen Manufacturing Sites and Area Served
    Table 11. Manufacturers Covid-19 Rapid Antigen Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Covid-19 Rapid Antigen by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Rapid Antigen as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Covid-19 Rapid Antigen Sales by Region (2017-2022) & (K Units)
    Table 16. Global Covid-19 Rapid Antigen Sales Market Share by Region (2017-2022)
    Table 17. Global Covid-19 Rapid Antigen Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Covid-19 Rapid Antigen Revenue Market Share by Region (2017-2022)
    Table 19. North America Covid-19 Rapid Antigen Sales by Country (2017-2022) & (K Units)
    Table 20. North America Covid-19 Rapid Antigen Sales Market Share by Country (2017-2022)
    Table 21. North America Covid-19 Rapid Antigen Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Covid-19 Rapid Antigen Revenue Market Share by Country (2017-2022)
    Table 23. Europe Covid-19 Rapid Antigen Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Covid-19 Rapid Antigen Sales Market Share by Country (2017-2022)
    Table 25. Europe Covid-19 Rapid Antigen Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Covid-19 Rapid Antigen Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Covid-19 Rapid Antigen Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Covid-19 Rapid Antigen Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Covid-19 Rapid Antigen Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Covid-19 Rapid Antigen Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Covid-19 Rapid Antigen Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Covid-19 Rapid Antigen Sales Market Share by Country (2017-2022)
    Table 33. Latin America Covid-19 Rapid Antigen Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Covid-19 Rapid Antigen Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Covid-19 Rapid Antigen Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Covid-19 Rapid Antigen Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Covid-19 Rapid Antigen Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Covid-19 Rapid Antigen Revenue Market Share by Country (2017-2022)
    Table 39. Global Covid-19 Rapid Antigen Sales by Sample Type (2017-2022) & (K Units)
    Table 40. Global Covid-19 Rapid Antigen Sales Market Share by Sample Type (2017-2022)
    Table 41. Global Covid-19 Rapid Antigen Revenue by Sample Type (2017-2022) & (US$ Million)
    Table 42. Global Covid-19 Rapid Antigen Revenue Share by Sample Type (2017-2022)
    Table 43. Global Covid-19 Rapid Antigen Price by Sample Type (2017-2022) & (US$/Unit)
    Table 44. Global Covid-19 Rapid Antigen Sales (K Units) by Application (2017-2022)
    Table 45. Global Covid-19 Rapid Antigen Sales Market Share by Application (2017-2022)
    Table 46. Global Covid-19 Rapid Antigen Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Covid-19 Rapid Antigen Revenue Share by Application (2017-2022)
    Table 48. Global Covid-19 Rapid Antigen Price by Application (2017-2022) & (US$/Unit)
    Table 49. Abbott Corporation Information
    Table 50. Abbott Description and Business Overview
    Table 51. Abbott Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Abbott Covid-19 Rapid Antigen Product
    Table 53. Abbott Recent Developments/Updates
    Table 54. Access Bio Corporation Information
    Table 55. Access Bio Description and Business Overview
    Table 56. Access Bio Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Access Bio Covid-19 Rapid Antigen Product
    Table 58. Access Bio Recent Developments/Updates
    Table 59. BD Corporation Information
    Table 60. BD Description and Business Overview
    Table 61. BD Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. BD Covid-19 Rapid Antigen Product
    Table 63. BD Recent Developments/Updates
    Table 64. Quidel Corporation Information
    Table 65. Quidel Description and Business Overview
    Table 66. Quidel Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. Quidel Covid-19 Rapid Antigen Product
    Table 68. Quidel Recent Developments/Updates
    Table 69. Fujirebio Corporation Information
    Table 70. Fujirebio Description and Business Overview
    Table 71. Fujirebio Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. Fujirebio Covid-19 Rapid Antigen Product
    Table 73. Fujirebio Recent Developments/Updates
    Table 74. Ellume Corporation Information
    Table 75. Ellume Description and Business Overview
    Table 76. Ellume Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Ellume Covid-19 Rapid Antigen Product
    Table 78. Ellume Recent Developments/Updates
    Table 79. OraSure Technologies Corporation Information
    Table 80. OraSure Technologies Description and Business Overview
    Table 81. OraSure Technologies Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. OraSure Technologies Covid-19 Rapid Antigen Product
    Table 83. OraSure Technologies Recent Developments/Updates
    Table 84. Clip Health Corporation Information
    Table 85. Clip Health Description and Business Overview
    Table 86. Clip Health Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. Clip Health Covid-19 Rapid Antigen Product
    Table 88. Clip Health Recent Developments/Updates
    Table 89. Celltrion Healthcare Corporation Information
    Table 90. Celltrion Healthcare Description and Business Overview
    Table 91. Celltrion Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. Celltrion Healthcare Covid-19 Rapid Antigen Product
    Table 93. Celltrion Healthcare Recent Developments/Updates
    Table 94. Salofa Oy Corporation Information
    Table 95. Salofa Oy Description and Business Overview
    Table 96. Salofa Oy Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Salofa Oy Covid-19 Rapid Antigen Product
    Table 98. Salofa Oy Recent Developments/Updates
    Table 99. iHealth Labs Corporation Information
    Table 100. iHealth Labs Description and Business Overview
    Table 101. iHealth Labs Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. iHealth Labs Covid-19 Rapid Antigen Product
    Table 103. iHealth Labs Recent Developments/Updates
    Table 104. Novegent Corporation Information
    Table 105. Novegent Description and Business Overview
    Table 106. Novegent Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. Novegent Covid-19 Rapid Antigen Product
    Table 108. Novegent Recent Developments/Updates
    Table 109. Hangzhou Alltest Biotech Corporation Information
    Table 110. Hangzhou Alltest Biotech Description and Business Overview
    Table 111. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product
    Table 113. Hangzhou Alltest Biotech Recent Developments/Updates
    Table 114. Guangzhou Decheng Biotechnology Corporation Information
    Table 115. Guangzhou Decheng Biotechnology Description and Business Overview
    Table 116. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 117. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product
    Table 118. Guangzhou Decheng Biotechnology Recent Developments/Updates
    Table 119. SD Biosensor Corporation Information
    Table 120. SD Biosensor Description and Business Overview
    Table 121. SD Biosensor Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 122. SD Biosensor Covid-19 Rapid Antigen Product
    Table 123. SD Biosensor Recent Developments/Updates
    Table 124. MP Biomedical Corporation Information
    Table 125. MP Biomedical Description and Business Overview
    Table 126. MP Biomedical Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 127. MP Biomedical Covid-19 Rapid Antigen Product
    Table 128. MP Biomedical Recent Developments/Updates
    Table 129. Jiangsu Well Biotech Corporation Information
    Table 130. Jiangsu Well Biotech Description and Business Overview
    Table 131. Jiangsu Well Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 132. Jiangsu Well Biotech Covid-19 Rapid Antigen Product
    Table 133. Jiangsu Well Biotech Recent Developments/Updates
    Table 134. CTK Biotech Corporation Information
    Table 135. CTK Biotech Description and Business Overview
    Table 136. CTK Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 137. CTK Biotech Covid-19 Rapid Antigen Product
    Table 138. CTK Biotech Recent Developments/Updates
    Table 139. Hangzhou Laihe Biotech Corporation Information
    Table 140. Hangzhou Laihe Biotech Description and Business Overview
    Table 141. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 142. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product
    Table 143. Hangzhou Laihe Biotech Recent Developments/Updates
    Table 144. Innovation Scientific Corporation Information
    Table 145. Innovation Scientific Description and Business Overview
    Table 146. Innovation Scientific Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 147. Innovation Scientific Covid-19 Rapid Antigen Product
    Table 148. Innovation Scientific Recent Developments/Updates
    Table 149. Biohit Healthcare Corporation Information
    Table 150. Biohit Healthcare Description and Business Overview
    Table 151. Biohit Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 152. Biohit Healthcare Covid-19 Rapid Antigen Product
    Table 153. Biohit Healthcare Recent Developments/Updates
    Table 154. ACON Biotech Corporation Information
    Table 155. ACON Biotech Description and Business Overview
    Table 156. ACON Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 157. ACON Biotech Covid-19 Rapid Antigen Product
    Table 158. ACON Biotech Recent Developments/Updates
    Table 159. Assure Tech Corporation Information
    Table 160. Assure Tech Description and Business Overview
    Table 161. Assure Tech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 162. Assure Tech Covid-19 Rapid Antigen Product
    Table 163. Assure Tech Recent Developments/Updates
    Table 164. Hangzhou Clongene Biotech Corporation Information
    Table 165. Hangzhou Clongene Biotech Description and Business Overview
    Table 166. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 167. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product
    Table 168. Hangzhou Clongene Biotech Recent Developments/Updates
    Table 169. Hangzhou Testsea Biotechnology Corporation Information
    Table 170. Hangzhou Testsea Biotechnology Description and Business Overview
    Table 171. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 172. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product
    Table 173. Hangzhou Testsea Biotechnology Recent Developments/Updates
    Table 174. Production Base and Market Concentration Rate of Raw Material
    Table 175. Key Suppliers of Raw Materials
    Table 176. Covid-19 Rapid Antigen Distributors List
    Table 177. Covid-19 Rapid Antigen Customers List
    Table 178. Covid-19 Rapid Antigen Market Trends
    Table 179. Covid-19 Rapid Antigen Market Drivers
    Table 180. Covid-19 Rapid Antigen Market Challenges
    Table 181. Covid-19 Rapid Antigen Market Restraints
    Table 182. Global Covid-19 Rapid Antigen Sales Forecast by Sample Type (2023-2028) & (K Units)
    Table 183. Global Covid-19 Rapid Antigen Sales Market Share Forecast by Sample Type (2023-2028)
    Table 184. Global Covid-19 Rapid Antigen Revenue Forecast by Sample Type (2023-2028) & (US$ Million)
    Table 185. Global Covid-19 Rapid Antigen Revenue Market Share Forecast by Sample Type (2023-2028)
    Table 186. Global Covid-19 Rapid Antigen Sales Forecast by Application (2023-2028) & (K Units)
    Table 187. Global Covid-19 Rapid Antigen Sales Market Share Forecast by Application (2023-2028)
    Table 188. Global Covid-19 Rapid Antigen Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 189. Global Covid-19 Rapid Antigen Revenue Market Share Forecast by Application (2023-2028)
    Table 190. Global Covid-19 Rapid Antigen Sales Forecast by Region (2023-2028) & (K Units)
    Table 191. Global Covid-19 Rapid Antigen Sales Market Share Forecast by Region (2023-2028)
    Table 192. Global Covid-19 Rapid Antigen Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 193. Global Covid-19 Rapid Antigen Revenue Market Share Forecast by Region (2023-2028)
    Table 194. Research Programs/Design for This Report
    Table 195. Key Data Information from Secondary Sources
    Table 196. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Covid-19 Rapid Antigen
    Figure 2. Global Covid-19 Rapid Antigen Market Share by Sample Type in 2021 & 2028
    Figure 3. Nasal Swab Product Picture
    Figure 4. Oral Fluid/Saliva Product Picture
    Figure 5. Global Covid-19 Rapid Antigen Market Share by Application in 2021 & 2028
    Figure 6. Hospitals
    Figure 7. Scientific Research
    Figure 8. Global Covid-19 Rapid Antigen Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 9. Global Covid-19 Rapid Antigen Market Size (2017-2028) & (US$ Million)
    Figure 10. Global Covid-19 Rapid Antigen Sales (2017-2028) & (K Units)
    Figure 11. Covid-19 Rapid Antigen Sales Share by Manufacturers in 2021
    Figure 12. Global Covid-19 Rapid Antigen Revenue Share by Manufacturers in 2021
    Figure 13. The Global 5 and 10 Largest Covid-19 Rapid Antigen Players: Market Share by Revenue in 2021
    Figure 14. Covid-19 Rapid Antigen Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 15. Global Covid-19 Rapid Antigen Sales Market Share by Region (2017-2022)
    Figure 16. Global Covid-19 Rapid Antigen Sales Market Share by Region in 2021
    Figure 17. Global Covid-19 Rapid Antigen Revenue Market Share by Region (2017-2022)
    Figure 18. Global Covid-19 Rapid Antigen Revenue Market Share by Region in 2021
    Figure 19. United States Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 20. Canada Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Germany Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. France Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. U.K. Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Italy Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Russia Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. China Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Japan Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. South Korea Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. India Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Australia Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. China Taiwan Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Indonesia Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Thailand Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Malaysia Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Mexico Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Brazil Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Argentina Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Turkey Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Saudi Arabia Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. UAE Covid-19 Rapid Antigen Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Sales Market Share of Covid-19 Rapid Antigen by Sample Type (2017-2022)
    Figure 42. Manufacturing Cost Structure of Covid-19 Rapid Antigen
    Figure 43. Manufacturing Process Analysis of Covid-19 Rapid Antigen
    Figure 44. Covid-19 Rapid Antigen Industrial Chain Analysis
    Figure 45. Channels of Distribution
    Figure 46. Distributors Profiles
    Figure 47. Bottom-up and Top-down Approaches for This Report
    Figure 48. Data Triangulation
    Figure 49. Key Executives Interviewed